Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Income Statement [Abstract]    
Revenues $ 6,428,963 $ 4,999,517
Cost of goods sold 5,503,448 3,929,832
Gross margin 925,515 1,069,685
Operating expenses    
Operations 1,353,904 590,342
Research and development 2,606,141 516,084
Sales and marketing 1,127,532 172,182
General and administrative 5,548,589 1,279,471
Stock based compensation 3,291,635 3,388,216
Total operating expenses 13,927,801 5,946,295
Operating loss (13,002,286) (4,876,610)
Other (income) expense    
Derivative expense 4,630,288
Change in fair value of derivative liability (1,042,129) 2,492,894
Investment income, net (355,769)
Interest expense 147,724 1,223,767
Other, net (62,984) 12,616
Other (income) expense (1,313,158) 8,359,565
Net loss $ (11,689,128) $ (13,236,175)
Loss per share - basic and diluted $ (0.24) $ (0.56)
basic and diluted 48,220,265 23,655,743